The β-tail domain (βTD) regulates physiologic ligand binding to integrin CD11b/CD18 by Vineet Gupta, Annette Gylling, José Luis Alonso, Takashi Sugimori,

Slides:



Advertisements
Similar presentations
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Advertisements

Volume 59, Issue 5, Pages (May 2001)
Does the Integrin αA Domain Act as a Ligand for its βA Domain?
David Craig, Mu Gao, Klaus Schulten, Viola Vogel  Structure 
Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling  Junichi Takagi, Benjamin M. Petre, Thomas.
Roles of RabGEF1/Rabex-5 domains in regulating FcϵRI surface expression and FcϵRI-dependent responses in mast cells by Janet Kalesnikoff, Eon J. Rios,
Ligand binding to integrin αvβ3requires tyrosine 178 in the αv subunit
Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis.
Functional analysis of the cytoplasmic domain of the integrin α1 subunit in endothelial cells by Tristin D. Abair, Nada Bulus, Corina Borza, Munirathinam.
Transglutaminase-mediated oligomerization of the fibrin(ogen) αC domains promotes integrin-dependent cell adhesion and signaling by Alexey M. Belkin, Galina.
Volume 25, Issue 4, Pages (October 2006)
Protein S Gla-domain mutations causing impaired Ca2+-induced phospholipid binding and severe functional protein S deficiency by Suely M. Rezende, David.
by Koji Nakamura, Alexander Malykhin, and K. Mark Coggeshall
by Anita Boyapati, Ming Yan, Luke F. Peterson, Joseph R
Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor γ-chain signaling by Li Shen, Marjolein van.
by Rafijul Bari, Teresa Bell, Wai-Hang Leung, Queenie P
Activation of the Erythropoietin Receptor Is Not Required for Internalization of Bound Erythropoietin by Diana L. Beckman, Lilie L. Lin, Mary E. Quinones,
ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding by Ana Kasirer-Friede, Jian Kang, Bryan.
CD74 induces TAp63 expression leading to B-cell survival
Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1 by Nijing Sheng,
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII by Kagehiro Amano,
Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface by Hironao Wakabayashi, Fatbardha Varfaj,
by Veerendra Munugalavadla, Jovencio Borneo, David A
by Jennifer Huggins, Tina Pellegrin, Raymond E
Α-Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation.
by Chungho Kim, Tong-Lay Lau, Tobias S. Ulmer, and Mark H. Ginsberg
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions by Claire Abbal, Martine Lambelet, Debora Bertaggia, Carole.
by Herbert Bosshart, and Ruth F. Jarrett
Clathrin-Mediated Endocytosis Persists during Unperturbed Mitosis
Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production in vitro by José Perdomo, Feng Yan,
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia by Lubica Rauova, Mortimer Poncz, Steven E.
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
Α-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 by Lucinda Furci, Francesca Sironi, Monica Tolazzi,
The p67 laminin receptor identifies human erythroid progenitor and precursor cells and is functionally important for their bone marrow lodgment by Halvard.
Volume 37, Issue 5, Pages (March 2010)
Structural Analysis of Engineered Bb Fragment of Complement Factor B
Metastatic State of Cancer Cells May Be Indicated by Adhesion Strength
Volume 115, Issue 2, Pages (August 1998)
Volume 59, Issue 5, Pages (May 2001)
Volume 15, Issue 6, Pages (December 2001)
Volume 3, Issue 5, Pages (May 2013)
HyeongJun Kim, Jen Hsin, Yanxin Liu, Paul R. Selvin, Klaus Schulten 
Erik Procko, Ian Ferrin-O'Connell, Sze-Ling Ng, Rachelle Gaudet 
A Tripartite Protein Complex with the Potential to Couple Synaptic Vesicle Exocytosis to Cell Adhesion in Brain  Stefan Butz, Masaya Okamoto, Thomas C.
by Silvia Mele, Stephen Devereux, Andrea G
Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow  Brian Savage, Fanny Almus-Jacobs, Zaverio M Ruggeri 
Volume 22, Issue 6, Pages (June 2005)
T exosomes bind MAdCAM-1 via RA-increased integrin α4β7.
Exosomal regulation of lymphocyte homing to the gut
Travis I. Moore, Jesse Aaron, Teng-Leong Chew, Timothy A. Springer 
Volume 19, Issue 3, Pages (September 2003)
Determination of the HLA-DM Interaction Site on HLA-DR Molecules
Structural Basis for Specific Recognition of Reelin by Its Receptors
Volume 11, Issue 8, Pages (April 2001)
Structural Insights into the pH-Dependent Conformational Change and Collagen Recognition of the Human Mannose Receptor  Zhenzheng Hu, Xiangyi Shi, Bowen.
Yi-Ping Hsueh, Eunjoon Kim, Morgan Sheng  Neuron 
Mechanisms Contributing to T Cell Receptor Signaling and Assembly Revealed by the Solution Structure of an Ectodomain Fragment of the CD3ϵγ Heterodimer 
STIL Microcephaly Mutations Interfere with APC/C-Mediated Degradation and Cause Centriole Amplification  Christian Arquint, Erich A. Nigg  Current Biology 
Michael S. Kuhns, Mark M. Davis  Immunity 
David Craig, Mu Gao, Klaus Schulten, Viola Vogel  Structure 
Probabilistic Modeling of Rosette Formation
Volume 58, Issue 3, Pages (September 2000)
Volume 18, Issue 3, Pages (April 2005)
Volume 8, Issue 2, Pages (February 1998)
Matthieu Chavent, Elena Seiradake, E. Yvonne Jones, Mark S.P. Sansom 
by Babs O. Fabriek, Robin van Bruggen, Dong Mei Deng, Antoon J. M
Volume 23, Issue 2, Pages (August 2005)
by Mark S. Cragg, H. T. Claude Chan, Mathew D
CD18 in Monogenic and Polygenic Inflammatory Processes of the Skin
Presentation transcript:

The β-tail domain (βTD) regulates physiologic ligand binding to integrin CD11b/CD18 by Vineet Gupta, Annette Gylling, José Luis Alonso, Takashi Sugimori, Petre Ianakiev, Jiang-Ping Xiong, and M. Amin Arnaout Blood Volume 109(8):3513-3520 April 15, 2007 ©2007 by American Society of Hematology

Spatial relationships of the βTD domain. Spatial relationships of the βTD domain. A ribbon diagram of a model of CD11b/CD18 based on the crystal structure of unliganded αVβ3 ectodomain.2 The 8 β2-subunit domains are labeled. The 5 CD11b-subunit domains αA (MIDAS ion in cyan), propeller (with 4 metal ions, orange circles), thigh, and calf-1 and -2 (light gray) are labeled. The metal ion in the α-genu (arrow) is in orange. The specificity-determining loop (SDL) in βA is indicated by an arrowhead. The C663-C687 disulfide bridge found at the bottom of the CD loop is shown in cyan. The position of the plasma membrane (PM) is indicated by a dotted line for orientation. (Inset) An enlarged image of the βTD's CD loop (brown, arrow) and F/α7 region (red) in the unliganded αVβ3 ectodomain.2 The ADMIDAS (adjacent to MIDAS) ion (magenta) links the α1′-α1 helix and F/α7 loop through D126D127 and M335 (equivalent to D119D120, E325 in the β2 subunit, respectively) (Cα is in green; oxygens, red). S123 in β3 (and S116 in β2) completes the metal coordination sphere. Vineet Gupta et al. Blood 2007;109:3513-3520 ©2007 by American Society of Hematology

Surface expression and iC3b binding of WT and mutant CD11b/CD18 in HEK293 cells. Surface expression and iC3b binding of WT and mutant CD11b/CD18 in HEK293 cells. (A) Histograms showing the relative binding of the heterodimer-specific mAb IB4 and the anti-CD11b mAb 44a to HEK293 cells expressing WT and βTD mutant CD11b/CD18 receptors. Binding of the respective antibody to the WT receptor was considered 100. Each histogram represents mean ± SD of triplicate determinations from a representative experiment (1 of 3 performed). (B) Western blots following 4% to 15% gradient SDS-PAGE showing the presence of CD18 in anti-CD11b (using mAb 44a) immunoprecipitates from HEK293 cells expressing WT (lane 1), AGAA (lane 2), DSSG (lane 3), NGTD CD11b/CD18 mutants (lane 4), and mock-transfected cells (lane 5). Approximately equivalent amounts of the immunoprecipitated receptors were loaded in each lane. The shift in CD18 in the NGTD mutant (lane 4) is consistent with attachment of a neo–N-glycan. Arrowheads indicate molecular weight markers at 100 kDa and 75 kDa (High MW Markers; Boston Bioproducts). No CD18 was seen in anti-CD11b immunoprecipitates from mock-transfected HEK293 cells (lane 5). (C) Histograms showing the relative binding of EiC3b to WT and βTD mutant CD11b/CD18 in buffer containing EDTA (5 mM), Ca2+ and Mg2+ (1 mM each), or Mn2+ (1 mM) and expressed as percentage of binding to WT obtained in the presence of 1 mM each of Ca2+ and Mg2+ after correcting for expression using mAb IB4 as described.9 Similar results were obtained when the activation-insensitive mAb 44a was used as reference (not shown). Each bar represents mean ± SD of triplicate determinations from a representative experiment (1 of 3 performed). Vineet Gupta et al. Blood 2007;109:3513-3520 ©2007 by American Society of Hematology

Physiologic ligand binding of K562 stably expressing WT and βTD mutant CD11b/CD18. Physiologic ligand binding of K562 stably expressing WT and βTD mutant CD11b/CD18. (A) Cell surface expression of CD11b/CD18 on K562 cells using flow cytometry. K562 cells were immunostained with the primary heterodimer-specific mAb IB4 (thick lines, unshaded area) or isotype-matched control mAb MOPC-173 (gray shaded area), washed, developed with FITC-rat anti–mouse IgG2a, and analyzed counting 10 000 events. Median fluorescence intensity (MFI) for mAb IB4 staining is shown in each panel. (B) Histograms showing the relative binding of iC3b to WT and mutant CD11b/CD18 in buffer containing 5 mM EDTA, 1 mM each of Ca2+ and Mg2+, or 1 mM Mn2+ expressed as the number of cells showing rosettes (more than 3 EiC3b bound per K562 cell) as a percentage of total number of cells counted in a rosetting assay. Each histogram represents mean ± SD of triplicate determinations from a representative experiment (1 of 3 performed). No binding was observed in EDTA and with mock-transfected cells. The methods are detailed in “Materials and methods.” (C) A titration ligand binding curve showing ligand binding (% rosetting) of an increasing number of EiC3b to a constant number of WT or NGTD mutant CD11b/CD18-expressing K562 cells in buffer containing 1 mM each of Ca2+ and Mg2+ or 1 mM Mn2+ (as labeled). Each data point represents mean ± SD of triplicate determinations. Not shown are rosetting results from mock-transfected cells (0 rosettes under all 3 buffer conditions). The graph shows that NGTD-expressing cells have a higher percentage of rosetting in physiologic buffer cells under all conditions tested as compared with WT cells. The difference is greatest when ligand is limiting (at EiC3b/K562 cell ratio of about 18). No difference is seen in mutant integrin binding to iC3b in the presence of Ca2++Mg2+ or Mn2+ at all ratios used. Vineet Gupta et al. Blood 2007;109:3513-3520 ©2007 by American Society of Hematology

Binding and spreading by WT and βTD mutant CD11b/CD18 to iC3b-coated plates. Binding and spreading by WT and βTD mutant CD11b/CD18 to iC3b-coated plates. (A) Histograms showing the relative binding of mock, WT, and mutant CD11b/CD18-expressing cells to iC3b-coated plates in buffer containing 1 mM each of Ca2+ and Mg2+ or 1 mM Mn2+ and expressed as the absolute number of adherent cells per well. Each histogram represents mean ± SD of triplicate determinations from a representative experiment (1 of 2 performed). The methods are detailed in “Materials and methods.” No iC3b binding was seen with mock, WT, or mutant CD11b/CD18 in the presence of EDTA (not shown). (B) Histograms showing the relative level of spreading by mock, WT, and mutant CD11b/CD18 cells to iC3b-coated plates in buffer containing 1 mM each of Ca2+ and Mg2+ and expressed as a percent of spread cells in the total field (more than 200 cells examined in multiple fields using phase-contrast microscopy). Spreading results are reported as histograms representing mean ± SD of triplicate experiments. The methods are detailed in “Materials and methods.” (C) Phase-contrast microscopy images (visualized using a Nikon Eclipse E800 microscope [Nikon, Melville, NY] equipped with a 20×/0.50 numerical aperture objective in TBS) showing the morphology of the cells (mock, WT, and mutant CD11b/CD18) after adhering to iC3b-coated plates for about 1.5 hours in buffer containing 1 mM each of Ca2+ and Mg2+. Images were acquired using SPOT version 4.5 (Diagnostic Instruments, Sterling Heights, MI) and were cropped using Adobe Photoshop version 5.0 (Adobe Systems, San Jose, CA). Vineet Gupta et al. Blood 2007;109:3513-3520 ©2007 by American Society of Hematology

Reactivity of WT and βTD mutant CD11b/CD18 with conformation-sensitive mAb 24. Reactivity of WT and βTD mutant CD11b/CD18 with conformation-sensitive mAb 24. FACS analysis of the reactivity of mAb 24 with WT and mutant CD11b/CD18-expressing K562 cells. Level of CD11b/CD18 surface expression was analyzed using mAb IB4. Mean fluorescence intensity (MFI) values for mAb staining are shown in each panel from a representative experiment (1 of 3 performed), except that MFI of mAb 24 staining is shown after subtraction of the background mock fluorescence staining levels and after normalization to the IB4 expression values. Vineet Gupta et al. Blood 2007;109:3513-3520 ©2007 by American Society of Hematology

Reactivity of WT and βTD mutant CD11b/CD18 with genu extension–dependent mAb KIM127. Reactivity of WT and βTD mutant CD11b/CD18 with genu extension–dependent mAb KIM127. FACS analysis of the reactivity of mAb KIM127 with WT and mutant CD11b/CD18-expressing K562 cells. Level of CD11b/CD18 surface expression was analyzed using mAb IB4. MFI values for mAb staining are shown in each panel from a representative experiment (1 of 3 performed), except that mean fluorescence intensity of KIM127 staining is shown after subtraction of the background mock fluorescence staining levels and after normalization to the IB4 expression values. No binding was observed with isotype control mAb (not shown). Vineet Gupta et al. Blood 2007;109:3513-3520 ©2007 by American Society of Hematology

A mechanistic model for the conformational changes during integrin activation and signaling. A mechanistic model for the conformational changes during integrin activation and signaling. (A) Schematic of the domain structure of low-affinity leg-bent CD11b/CD18 (CD11b and CD18 in dark and light gray, respectively). βTD contacts the βA and hybrid domains, and the 2 legs are in close proximity. The αA is occupied by a metal ion in the low-affinity MIDAS (asterisk); the bottom of α7 helix of inactive αA (thick black arrow) is not engaged by βA. (B) Inside-out activation disrupts the βTD contact with βA, which unlocks the βA F/α7 loop and allows the inward shift of the α1 helix leading to the formation of a stable αA-bound βA MIDAS (asterisk), which in turn stabilizes αA in the open (high-affinity) state (open semicircle). (C-D) Ligand (L) (black circle on a stick) bound at αA MIDAS stabilizes the occupancy of βA MIDAS by endogenous αA, opening the βA/hybrid hinge to different degrees (double-headed arrows), with a larger hinge opening forcing genu extension and leg separation (D), resulting in outside-in signaling. See text for additional details. Vineet Gupta et al. Blood 2007;109:3513-3520 ©2007 by American Society of Hematology